| What does the term FL-LPA stand for? | First line - Line probe assay | Km, Cm, Lzd) **LPA may be done directly if smear +ve else send for MGIT followed by FLPA to evaluate for H (inhA and/ or KatG mutn) and Eto (inhA) resistance ADA: Adenosine Deaminase BAL: Broncho-alveolar lavage CBNAAT: Cartidge-based Nucleic Acid Amplification test CECT: Contrast enhanced CT CP: Continuation phase CT: Computed tomography DRTB: Drug resistant TB DST: Drug sensitivity test EPTB: Extra-pulmonary TB ETO: Ethionamide FDC: Fixed dose combination FL-LPA: First line - Line probe assay FQ: Fluoroquinolones GA: Gastric aspirate H: Isoniazid HIV: Human Immunodeficiency virus HRZE: Isoniazid; Rifampicin; Pyrazinamide; Ethambutol IGRA: Interferon Gamma Release assay IS: Induced sputum LN: Lymph node MAC: Mid Arm Circumference MTB: Mycobacterium Tuberculosis NAAT: Nucleic acid amplification test PPD: Purified Protein Derivative RIF: Rifampicin SAM: Severe acute malnutrition SLI: Second line injectables SL-LPA: Second line - Line probe assay TST: Tuberculin skin test USG: Ultrasonography ZN: Ziehl Neelson | 470 | definition | 0.980 | https://www.icmr.gov.in/icmrobject/uploads/STWs/1725964684_2_paediatric_intrathoracis_tb.pdf | Km, Cm, Lzd) **LPA may be done directly if smear +ve else send for MGIT followed by FLPA to evaluate for H (inhA and/ or KatG mutn) and Eto (inhA) resistance ADA: Adenosine Deaminase BAL: Broncho-alveolar lavage CBNAAT: Cartidge-based Nucleic Acid Amplification test CECT: Contrast enhanced CT CP: Continuation phase CT: Computed tomography DRTB: Drug resistant TB DST: Drug sensitivity test EPTB: Extra-pulmonary TB ETO: Ethionamide FDC: Fixed dose combination FL-LPA: First line - Line probe assay FQ: Fluoroquinolones GA: Gastric aspirate H: Isoniazid HIV: Human Immunodeficiency virus HRZE: | 1 | page=1,block=153 | 0.700 | valid |
| What is the full form of CBNAAT? | Cartidge-based Nucleic Acid Amplification test | Km, Cm, Lzd) **LPA may be done directly if smear +ve else send for MGIT followed by FLPA to evaluate for H (inhA and/ or KatG mutn) and Eto (inhA) resistance ADA: Adenosine Deaminase BAL: Broncho-alveolar lavage CBNAAT: Cartidge-based Nucleic Acid Amplification test CECT: Contrast enhanced CT CP: Continuation phase CT: Computed tomography DRTB: Drug resistant TB DST: Drug sensitivity test EPTB: Extra-pulmonary TB ETO: Ethionamide FDC: Fixed dose combination FL-LPA: First line - Line probe assay FQ: Fluoroquinolones GA: Gastric aspirate H: Isoniazid HIV: Human Immunodeficiency virus HRZE: Isoniazid; Rifampicin; Pyrazinamide; Ethambutol IGRA: Interferon Gamma Release assay IS: Induced sputum LN: Lymph node MAC: Mid Arm Circumference MTB: Mycobacterium Tuberculosis NAAT: Nucleic acid amplification test PPD: Purified Protein Derivative RIF: Rifampicin SAM: Severe acute malnutrition SLI: Second line injectables SL-LPA: Second line - Line probe assay TST: Tuberculin skin test USG: Ultrasonography ZN: Ziehl Neelson | 220 | definition | 0.980 | https://www.icmr.gov.in/icmrobject/uploads/STWs/1725964684_2_paediatric_intrathoracis_tb.pdf | Km, Cm, Lzd) **LPA may be done directly if smear +ve else send for MGIT followed by FLPA to evaluate for H (inhA and/ or KatG mutn) and Eto (inhA) resistance ADA: Adenosine Deaminase BAL: Broncho-alveolar lavage CBNAAT: Cartidge-based Nucleic Acid Amplification test CECT: Contrast enhanced CT CP: Continuation phase CT: Computed tomography DRTB: Drug resistant TB DST: Drug sensitivity test EPTB: Extra-pulmonary TB ETO: Ethionamide FDC: Fixed dose combination FL-LPA: First line - Line probe assay FQ: Fluoroquinolones GA: Gastric aspirate H: Isoniazid HIV: Human Immunodeficiency virus HRZE: |
| What condition makes Rif resistance detection less reliable in a new case with no risk factors for DRTB? | only MTB detected is very low | +ve $RR detected in new case with no risk factors for DRTB needs retesting if only MTB detected is very low as it makes Rif resistance detection less reliable * SLLPA may be done directly if smear +ve else send for MGIT followed by SLLPA or LC DST (Mfx 2. | 78 | relationship | 0.970 | https://www.icmr.gov.in/icmrobject/uploads/STWs/1725964684_2_paediatric_intrathoracis_tb.pdf | +ve $RR detected in new case with no risk factors for DRTB needs retesting if only MTB detected is very low as it makes Rif resistance detection less reliable * SLLPA may be done directly if smear +ve else send for MGIT followed by SLLPA or LC DST (Mfx 2. | 1 | page=1,block=153 | 0.700 | valid |
| What is the meaning of the abbreviation DST? | Drug sensitivity test | Km, Cm, Lzd) **LPA may be done directly if smear +ve else send for MGIT followed by FLPA to evaluate for H (inhA and/ or KatG mutn) and Eto (inhA) resistance ADA: Adenosine Deaminase BAL: Broncho-alveolar lavage CBNAAT: Cartidge-based Nucleic Acid Amplification test CECT: Contrast enhanced CT CP: Continuation phase CT: Computed tomography DRTB: Drug resistant TB DST: Drug sensitivity test EPTB: Extra-pulmonary TB ETO: Ethionamide FDC: Fixed dose combination FL-LPA: First line - Line probe assay FQ: Fluoroquinolones GA: Gastric aspirate H: Isoniazid HIV: Human Immunodeficiency virus HRZE: Isoniazid; Rifampicin; Pyrazinamide; Ethambutol IGRA: Interferon Gamma Release assay IS: Induced sputum LN: Lymph node MAC: Mid Arm Circumference MTB: Mycobacterium Tuberculosis NAAT: Nucleic acid amplification test PPD: Purified Protein Derivative RIF: Rifampicin SAM: Severe acute malnutrition SLI: Second line injectables SL-LPA: Second line - Line probe assay TST: Tuberculin skin test USG: Ultrasonography ZN: Ziehl Neelson | 370 | definition | 0.940 | https://www.icmr.gov.in/icmrobject/uploads/STWs/1725964684_2_paediatric_intrathoracis_tb.pdf | Km, Cm, Lzd) **LPA may be done directly if smear +ve else send for MGIT followed by FLPA to evaluate for H (inhA and/ or KatG mutn) and Eto (inhA) resistance ADA: Adenosine Deaminase BAL: Broncho-alveolar lavage CBNAAT: Cartidge-based Nucleic Acid Amplification test CECT: Contrast enhanced CT CP: Continuation phase CT: Computed tomography DRTB: Drug resistant TB DST: Drug sensitivity test EPTB: Extra-pulmonary TB ETO: Ethionamide FDC: Fixed dose combination FL-LPA: First line - Line probe assay FQ: Fluoroquinolones GA: Gastric aspirate H: Isoniazid HIV: Human Immunodeficiency virus HRZE: |
| What might chest examination findings depend upon? | underlying pathology like consolidation, pleural effusion | Unexplained docu- mented weight loss of ≥ 5% in last 3 months • Temperature, Weight, Mid Arm Circumference (MAC), Lymphadenopathy, cold abscess, discharging sinus • Chest examination findings depend upon underlying pathology like consolidation, pleural effusion etc. Unremitting cough for | 204 | relationship | 0.930 | https://www.icmr.gov.in/icmrobject/uploads/STWs/1725964684_2_paediatric_intrathoracis_tb.pdf | Unexplained docu- mented weight loss of ≥ 5% in last 3 months • Temperature, Weight, Mid Arm Circumference (MAC), Lymphadenopathy, cold abscess, discharging sinus • Chest examination findings depend upon underlying pathology like consolidation, pleural effusion etc. | 1 | page=1,block=0 | 0.700 | valid |
| What does the abbreviation ADA stand for? | Adenosine Deaminase | Km, Cm, Lzd) **LPA may be done directly if smear +ve else send for MGIT followed by FLPA to evaluate for H (inhA and/ or KatG mutn) and Eto (inhA) resistance ADA: Adenosine Deaminase BAL: Broncho-alveolar lavage CBNAAT: Cartidge-based Nucleic Acid Amplification test CECT: Contrast enhanced CT CP: Continuation phase CT: Computed tomography DRTB: Drug resistant TB DST: Drug sensitivity test EPTB: Extra-pulmonary TB ETO: Ethionamide FDC: Fixed dose combination FL-LPA: First line - Line probe assay FQ: Fluoroquinolones GA: Gastric aspirate H: Isoniazid HIV: Human Immunodeficiency virus HRZE: Isoniazid; Rifampicin; Pyrazinamide; Ethambutol IGRA: Interferon Gamma Release assay IS: Induced sputum LN: Lymph node MAC: Mid Arm Circumference MTB: Mycobacterium Tuberculosis NAAT: Nucleic acid amplification test PPD: Purified Protein Derivative RIF: Rifampicin SAM: Severe acute malnutrition SLI: Second line injectables SL-LPA: Second line - Line probe assay TST: Tuberculin skin test USG: Ultrasonography ZN: Ziehl Neelson | 163 | definition | 0.900 | https://www.icmr.gov.in/icmrobject/uploads/STWs/1725964684_2_paediatric_intrathoracis_tb.pdf | Km, Cm, Lzd) **LPA may be done directly if smear +ve else send for MGIT followed by FLPA to evaluate for H (inhA and/ or KatG mutn) and Eto (inhA) resistance ADA: Adenosine Deaminase BAL: Broncho-alveolar lavage CBNAAT: Cartidge-based Nucleic Acid Amplification test CECT: Contrast enhanced CT CP: Continuation phase CT: Computed tomography DRTB: Drug resistant TB DST: Drug sensitivity test EPTB: Extra-pulmonary TB ETO: Ethionamide FDC: Fixed dose combination FL-LPA: First line - Line probe assay FQ: Fluoroquinolones GA: Gastric aspirate H: Isoniazid HIV: Human Immunodeficiency virus HRZE: |
| What does the abbreviation BAL stand for? | Broncho-alveolar lavage | Km, Cm, Lzd) **LPA may be done directly if smear +ve else send for MGIT followed by FLPA to evaluate for H (inhA and/ or KatG mutn) and Eto (inhA) resistance ADA: Adenosine Deaminase BAL: Broncho-alveolar lavage CBNAAT: Cartidge-based Nucleic Acid Amplification test CECT: Contrast enhanced CT CP: Continuation phase CT: Computed tomography DRTB: Drug resistant TB DST: Drug sensitivity test EPTB: Extra-pulmonary TB ETO: Ethionamide FDC: Fixed dose combination FL-LPA: First line - Line probe assay FQ: Fluoroquinolones GA: Gastric aspirate H: Isoniazid HIV: Human Immunodeficiency virus HRZE: Isoniazid; Rifampicin; Pyrazinamide; Ethambutol IGRA: Interferon Gamma Release assay IS: Induced sputum LN: Lymph node MAC: Mid Arm Circumference MTB: Mycobacterium Tuberculosis NAAT: Nucleic acid amplification test PPD: Purified Protein Derivative RIF: Rifampicin SAM: Severe acute malnutrition SLI: Second line injectables SL-LPA: Second line - Line probe assay TST: Tuberculin skin test USG: Ultrasonography ZN: Ziehl Neelson | 188 | definition | 0.900 | https://www.icmr.gov.in/icmrobject/uploads/STWs/1725964684_2_paediatric_intrathoracis_tb.pdf | Km, Cm, Lzd) **LPA may be done directly if smear +ve else send for MGIT followed by FLPA to evaluate for H (inhA and/ or KatG mutn) and Eto (inhA) resistance ADA: Adenosine Deaminase BAL: Broncho-alveolar lavage CBNAAT: Cartidge-based Nucleic Acid Amplification test CECT: Contrast enhanced CT CP: Continuation phase CT: Computed tomography DRTB: Drug resistant TB DST: Drug sensitivity test EPTB: Extra-pulmonary TB ETO: Ethionamide FDC: Fixed dose combination FL-LPA: First line - Line probe assay FQ: Fluoroquinolones GA: Gastric aspirate H: Isoniazid HIV: Human Immunodeficiency virus HRZE: |
| What does the abbreviation CP refer to? | Continuation phase | Km, Cm, Lzd) **LPA may be done directly if smear +ve else send for MGIT followed by FLPA to evaluate for H (inhA and/ or KatG mutn) and Eto (inhA) resistance ADA: Adenosine Deaminase BAL: Broncho-alveolar lavage CBNAAT: Cartidge-based Nucleic Acid Amplification test CECT: Contrast enhanced CT CP: Continuation phase CT: Computed tomography DRTB: Drug resistant TB DST: Drug sensitivity test EPTB: Extra-pulmonary TB ETO: Ethionamide FDC: Fixed dose combination FL-LPA: First line - Line probe assay FQ: Fluoroquinolones GA: Gastric aspirate H: Isoniazid HIV: Human Immunodeficiency virus HRZE: Isoniazid; Rifampicin; Pyrazinamide; Ethambutol IGRA: Interferon Gamma Release assay IS: Induced sputum LN: Lymph node MAC: Mid Arm Circumference MTB: Mycobacterium Tuberculosis NAAT: Nucleic acid amplification test PPD: Purified Protein Derivative RIF: Rifampicin SAM: Severe acute malnutrition SLI: Second line injectables SL-LPA: Second line - Line probe assay TST: Tuberculin skin test USG: Ultrasonography ZN: Ziehl Neelson | 298 | definition | 0.900 | https://www.icmr.gov.in/icmrobject/uploads/STWs/1725964684_2_paediatric_intrathoracis_tb.pdf | Km, Cm, Lzd) **LPA may be done directly if smear +ve else send for MGIT followed by FLPA to evaluate for H (inhA and/ or KatG mutn) and Eto (inhA) resistance ADA: Adenosine Deaminase BAL: Broncho-alveolar lavage CBNAAT: Cartidge-based Nucleic Acid Amplification test CECT: Contrast enhanced CT CP: Continuation phase CT: Computed tomography DRTB: Drug resistant TB DST: Drug sensitivity test EPTB: Extra-pulmonary TB ETO: Ethionamide FDC: Fixed dose combination FL-LPA: First line - Line probe assay FQ: Fluoroquinolones GA: Gastric aspirate H: Isoniazid HIV: Human Immunodeficiency virus HRZE: |
| What does the abbreviation EPTB refer to? | Extra-pulmonary TB | Km, Cm, Lzd) **LPA may be done directly if smear +ve else send for MGIT followed by FLPA to evaluate for H (inhA and/ or KatG mutn) and Eto (inhA) resistance ADA: Adenosine Deaminase BAL: Broncho-alveolar lavage CBNAAT: Cartidge-based Nucleic Acid Amplification test CECT: Contrast enhanced CT CP: Continuation phase CT: Computed tomography DRTB: Drug resistant TB DST: Drug sensitivity test EPTB: Extra-pulmonary TB ETO: Ethionamide FDC: Fixed dose combination FL-LPA: First line - Line probe assay FQ: Fluoroquinolones GA: Gastric aspirate H: Isoniazid HIV: Human Immunodeficiency virus HRZE: Isoniazid; Rifampicin; Pyrazinamide; Ethambutol IGRA: Interferon Gamma Release assay IS: Induced sputum LN: Lymph node MAC: Mid Arm Circumference MTB: Mycobacterium Tuberculosis NAAT: Nucleic acid amplification test PPD: Purified Protein Derivative RIF: Rifampicin SAM: Severe acute malnutrition SLI: Second line injectables SL-LPA: Second line - Line probe assay TST: Tuberculin skin test USG: Ultrasonography ZN: Ziehl Neelson | 398 | definition | 0.900 | https://www.icmr.gov.in/icmrobject/uploads/STWs/1725964684_2_paediatric_intrathoracis_tb.pdf | Km, Cm, Lzd) **LPA may be done directly if smear +ve else send for MGIT followed by FLPA to evaluate for H (inhA and/ or KatG mutn) and Eto (inhA) resistance ADA: Adenosine Deaminase BAL: Broncho-alveolar lavage CBNAAT: Cartidge-based Nucleic Acid Amplification test CECT: Contrast enhanced CT CP: Continuation phase CT: Computed tomography DRTB: Drug resistant TB DST: Drug sensitivity test EPTB: Extra-pulmonary TB ETO: Ethionamide FDC: Fixed dose combination FL-LPA: First line - Line probe assay FQ: Fluoroquinolones GA: Gastric aspirate H: Isoniazid HIV: Human Immunodeficiency virus HRZE: |
| What does the abbreviation FDC stand for? | Fixed dose combination | Km, Cm, Lzd) **LPA may be done directly if smear +ve else send for MGIT followed by FLPA to evaluate for H (inhA and/ or KatG mutn) and Eto (inhA) resistance ADA: Adenosine Deaminase BAL: Broncho-alveolar lavage CBNAAT: Cartidge-based Nucleic Acid Amplification test CECT: Contrast enhanced CT CP: Continuation phase CT: Computed tomography DRTB: Drug resistant TB DST: Drug sensitivity test EPTB: Extra-pulmonary TB ETO: Ethionamide FDC: Fixed dose combination FL-LPA: First line - Line probe assay FQ: Fluoroquinolones GA: Gastric aspirate H: Isoniazid HIV: Human Immunodeficiency virus HRZE: Isoniazid; Rifampicin; Pyrazinamide; Ethambutol IGRA: Interferon Gamma Release assay IS: Induced sputum LN: Lymph node MAC: Mid Arm Circumference MTB: Mycobacterium Tuberculosis NAAT: Nucleic acid amplification test PPD: Purified Protein Derivative RIF: Rifampicin SAM: Severe acute malnutrition SLI: Second line injectables SL-LPA: Second line - Line probe assay TST: Tuberculin skin test USG: Ultrasonography ZN: Ziehl Neelson | 439 | definition | 0.900 | https://www.icmr.gov.in/icmrobject/uploads/STWs/1725964684_2_paediatric_intrathoracis_tb.pdf | Km, Cm, Lzd) **LPA may be done directly if smear +ve else send for MGIT followed by FLPA to evaluate for H (inhA and/ or KatG mutn) and Eto (inhA) resistance ADA: Adenosine Deaminase BAL: Broncho-alveolar lavage CBNAAT: Cartidge-based Nucleic Acid Amplification test CECT: Contrast enhanced CT CP: Continuation phase CT: Computed tomography DRTB: Drug resistant TB DST: Drug sensitivity test EPTB: Extra-pulmonary TB ETO: Ethionamide FDC: Fixed dose combination FL-LPA: First line - Line probe assay FQ: Fluoroquinolones GA: Gastric aspirate H: Isoniazid HIV: Human Immunodeficiency virus HRZE: |